OutPerformDaily

  • Tech Stocks
  • Cannabis Stocks
  • Index Funds
  • International
  • Short
  • Stock Picks

Lost Password?

Is Apple’s foldable iPhone Duo worth $2,000? See how it stacks up against other foldable phones.

I gave my HomeExchange guest a 5-star review. Then I found heat marks all over my dining table. Do I call her out?

Inside the push to weaken Washington’s toughest financial watchdog

Scared to spend your retirement money? Here’s one way to get over the fear of running out.

It’s ‘unavoidable’: Apple says it will be forced to raise prices due to the AI boom

Did Warsh and Vance just open the door to higher inflation?

OutPerformDaily
  • Tech Stocks
  • Cannabis Stocks
  • Index Funds
  • International
  • Short
  • Stock Picks
OutPerformDaily
  • Tech Stocks
  • Cannabis Stocks
  • Index Funds
  • International
  • Short
  • Stock Picks
3rdPartyFeeds

GW Pharmaceuticals and U.S. Subsidiary Greenwich Biosciences to Present Data on Epidiolex® (cannabidiol) oral solution, CV at the 2019 American Academy of Neurology Annual Meeting

May 2, 2019

GW Pharmaceuticals plc (Nasdaq: GWPH, “GW,” “the Company” or “the Group”), the world leader in the development and commercialization of cannabinoid...

3rdPartyFeeds

Why Aurora Cannabis hasn’t signed a deal with a U.S. giant like other pot companies

May 2, 2019

Aurora Cannabis Inc. is one of two major Canadian cannabis companies with a market value of more than $1.5 billion that has yet to ink a partnership or...

3rdPartyFeeds • News

TurboTax denies low-income customers were cheated out of free tax prep — tells customers it’s ‘fake news’

May 2, 2019

A ProPublica investigation says TurboTax steered customers to its paid product, even if they were eligible for services at no charge.

Read More...

3rdPartyFeeds

DowDuPont profit slumps 28%, hit by lower chemical demand

May 2, 2019

Floods in the U.S. Midwest and a sluggish growth in auto and smartphone markets hit prices of its specialty and agricultural chemicals as well as volumes in...

3rdPartyFeeds • News

Next Avenue: Why your doctor may give you a ‘social prescription’

May 2, 2019

They improve the health and well-being of people with a variety of long-term conditions.

Read More...

3rdPartyFeeds

Sainsbury’s takes on Amazon by selling third-party products

May 2, 2019

Britain’s second-biggest supermarket chain plans to compete head-on with Amazon (AMZN) by selling third-party products and services. Sainsbury’s (UK:SBRY) ...

3rdPartyFeeds • News

Credit.com: Is your credit just ‘fair?’ Here are some credit card options

May 2, 2019

With middling credit, you probably have a card, but how about one that boosts your score and offers rewards?

Read More...

3rdPartyFeeds

Vegan burger company Beyond Meat’s IPO sizzles with $25 share price

May 2, 2019

Plant-based meat substitutes have been gaining popularity as more attention is focused on the environmental hazards of industrial ranching. The company had...

3rdPartyFeeds • News

American Express relaunches Blue Cash Preferred credit card — with cashback for Netflix, Amazon, Lyft and Uber

May 2, 2019

Card holders will earn cash back on new categories, including streaming services.

Read More...

3rdPartyFeeds

Dow Jones Futures: Stock Market Sends Message; Qualcomm, Square Fall On Guidance

May 2, 2019

Stock futures were little changed after the major indexes and several top stocks reversed lower Wednesday. Qualcomm, Square, Cree and Ceridian fell late on...

Previous 1 … 8,306 8,307 8,308 8,309 8,310 … 8,455 Next
Indices by TradingView

Is Apple’s foldable iPhone Duo worth $2,000? See how it stacks up against other foldable phones.

October 17, 2026

Categories

  • 3rdPartyFeeds
  • Cannabis Stocks
  • Index Funds
  • International
  • News
  • Short
  • Stock Picks
  • Tech Stocks
  • Uncategorized
Indices by TradingView
While subscribers receive the benefit of Outperformdaily opinions, none of the information contained therein constitutes a recommendation from Outperformdaily that any particular security, portfolio of securities, transaction, option, or investment strategy is suitable for any specific person. You further understand that we will not advise you personally concerning the nature, potential, value or suitability of any particular security, portfolio of securities, transaction, investment strategy or other matter. To the extent any of the information contained in Outperformdaily may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person. Outperformdaily’s past results are not necessarily indicative of future performance. All investments are subject to loss. Our employees and writters typically personally invest in all recommendations, but they are not obligated too. Our employees and writters are prohibited from taking an opposite position from which they write about.